173 related articles for article (PubMed ID: 24250026)
1. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in a case of malignant peripheral nerve sheath tumor: An unusual presentation.
D'souza MM; Jaimini A; Kumar Dhali T; D'souza P; Saw S; Sharma R; Mondal A
Indian J Nucl Med; 2013 Jul; 28(3):168-70. PubMed ID: 24250026
[TBL] [Abstract][Full Text] [Related]
2. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
[TBL] [Abstract][Full Text] [Related]
3. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
4. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
5. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
6. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
8. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
9. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography Masquerading as a Case of Sporadic Malignant Peripheral Nerve Sheath Tumor of Lower Extremity Presenting as Massive Lower Limb Edema.
Singh D; Kumar R; Das A; Varma SC; Mittal BR
World J Nucl Med; 2017; 16(4):324-327. PubMed ID: 29033684
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
Raad RA; Lala S; Allen JC; Babb J; Mitchell CW; Franceschi AM; Yohay K; Friedman KP
World J Nucl Med; 2018; 17(4):241-248. PubMed ID: 30505221
[TBL] [Abstract][Full Text] [Related]
12. Malignant Peripheral Nerve Sheath Tumor.
James AW; Shurell E; Singh A; Dry SM; Eilber FC
Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
[TBL] [Abstract][Full Text] [Related]
13. Malignant peripheral nerve sheath tumor in the pelvis: a case report.
Ono R; Tominaga T; Nonaka T; Takamura Y; Oishi K; Shiraishi T; Hashimoto S; Noda K; Sawai T; Nagayasu T
Surg Case Rep; 2023 Sep; 9(1):157. PubMed ID: 37672135
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose positron emission tomography findings of peripheral nerve sheath tumour of the nasal cavity in a dog.
Lee D; Yun H; Yun T; Koo Y; Chae Y; Nam H; Kang S; Lee H; Chang D; Yang MP; Kang BT; Kim H
Vet Med Sci; 2023 Mar; 9(2):584-590. PubMed ID: 36626300
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Chirindel A; Chaudhry M; Blakeley JO; Wahl R
J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
[TBL] [Abstract][Full Text] [Related]
16. Malignant peripheral nerve sheath tumor of thigh with sphenoid and brain metastases: Extremely rare occurrence with dismal prognosis despite significant response to palliative chemoradiotherapy.
Purkayastha A; Singh S; Kapoor A; Bhatia JK; Bisht N; Husain A
World J Nucl Med; 2019; 18(3):296-300. PubMed ID: 31516375
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI.
Reinert CP; Schuhmann MU; Bender B; Gugel I; la Fougère C; Schäfer J; Gatidis S
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):776-787. PubMed ID: 30535768
[TBL] [Abstract][Full Text] [Related]
18. Mixed malignant peripheral nerve sheath tumor in the inguinal region: a case report.
Liu M; Liu S; Zhan J; Chen W; Yang P; Zhou H
Int J Clin Exp Pathol; 2020; 13(2):261-265. PubMed ID: 32211107
[TBL] [Abstract][Full Text] [Related]
19. Malignant Peripheral Nerve Sheath Tumors Without Muscle Weakness at Presentation: An Analysis of an Underappreciated Combination.
Maldonado AA; Everson MC; Puffer RC; Broski SM; Howe BM; Spinner RJ
World Neurosurg; 2022 Aug; 164():e335-e340. PubMed ID: 35513276
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review.
Treglia G; Taralli S; Bertagna F; Salsano M; Muoio B; Novellis P; Vita ML; Maggi F; Giordano A
Radiol Res Pract; 2012; 2012():431029. PubMed ID: 22991664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
